Quote | Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Last: | $6.1901 |
---|---|
Change Percent: | -2.82% |
Open: | $6.32 |
Close: | $6.37 |
High: | $6.32 |
Low: | $6.13 |
Volume: | 4,673 |
Last Trade Date Time: | 07/18/2024 03:00:00 am |
News | Foghorn Therapeutics Inc. (NASDAQ:FHTX)
2024-07-18 00:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-06 14:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Subject | By | Source | When |
---|---|---|---|
Long and strong lets hope im right | crudeoil24 | investorshub | 06/27/2023 4:16:58 AM |
$FHTX news all the way baby | crudeoil24 | investorshub | 06/25/2023 10:25:45 PM |
$FHTX is it bear time? Or do we go bull? | crudeoil24 | investorshub | 06/20/2023 6:01:01 AM |
$FHTX Long and strong lets hope im right | Surfacetite | investorshub | 06/14/2023 6:34:57 AM |
great news | crudeoil24 | investorshub | 06/13/2023 3:47:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Foghorn Therapeutics Inc. Company Name:
FHTX Stock Symbol:
NASDAQ Market:
Foghorn Therapeutics Inc. Website:
2024-07-18 00:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-06 14:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jeffe...